UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

Inflammatory bowel diseases, 2012-12, Vol.18 (12), p.2218-2224

2012

Volltextzugriff (PDF)

Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2017-10, Vol.23 (10), p.1718-1729

2017

Volltextzugriff (PDF)

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

Journal of Crohn's and colitis, 2017-01, Vol.11 (1), p.26-34

2017

Volltextzugriff (PDF)

Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates

Journal of Crohn's and colitis, 2019-07, Vol.13 (7), p.864-872

2019

Volltextzugriff (PDF)

Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase Studies

Journal of Crohn's and colitis, 2018-08, Vol.12 (9), p.1011-1013

2018

Volltextzugriff (PDF)

Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1194-1201

2013

Volltextzugriff (PDF)

Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?

Journal of Crohn's and colitis, 2017-03, Vol.11 (3), p.378

2017

Volltextzugriff (PDF)

The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients

Journal of Crohn's and colitis, 2015-10, Vol.9 (10), p.846-852

2015

Volltextzugriff (PDF)

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease

Journal of Crohn's and colitis, 2018-04, Vol.12 (4), p.402-407

2018

Volltextzugriff (PDF)

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Inflammatory bowel diseases, 2018-04, Vol.24 (5), p.1099-1105

2018

Volltextzugriff (PDF)

Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis

Inflammatory bowel diseases, 2014-07, Vol.20 (7), p.1198-1207

2014

Volltextzugriff (PDF)

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease

Journal of Crohn's and colitis, 2015-12, Vol.9 (12), p.1120-1126

2015

Volltextzugriff (PDF)

Efficacy of infliximab in refractory pouchitis and Crohn's disease‐related complications of the pouch: A Belgian case series

Inflammatory bowel diseases, 2010-02, Vol.16 (2), p.243-249

2010

Volltextzugriff (PDF)

Long-term outcome after infliximab for refractory ulcerative colitis

Journal of Crohn's and colitis, 2008-09, Vol.2 (3), p.219-225

2008

Volltextzugriff (PDF)

Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases

Inflammatory bowel diseases, 2015-12, Vol.21 (12), p.2787-2796

2015

Volltextzugriff (PDF)

ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior

Journal of Crohn's and colitis, 2014-06, Vol.8 (6), p.489-494

2014

Volltextzugriff (PDF)

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD

Journal of Crohn's and colitis, 2021-07, Vol.15 (7), p.1222-1235

2021

Volltextzugriff (PDF)

Efficacy of JAK inhibitors in Ulcerative Colitis

Journal of Crohn's and colitis, 2020-08, Vol.14 (Supplement_2), p.S737-S745

2020

Volltextzugriff (PDF)

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2021-10, Vol.27 (10), p.1564-1575

2021

Volltextzugriff (PDF)

A Simplified Geboes Score for Ulcerative Colitis

Journal of Crohn's and colitis, 2016-08, p.jjw154

2016

Volltextzugriff (PDF)

Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2016-04, Vol.10 (4), p.387-394

2016

Volltextzugriff (PDF)

Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD

Inflammatory bowel diseases, 2022-08, Vol.28 (8), p.1135-1142

2022

Volltextzugriff (PDF)

Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window

Inflammatory bowel diseases, 2017-09, Vol.23 (9), p.1510-1515

2017

Volltextzugriff (PDF)

Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis

Inflammatory bowel diseases, 2021-05, Vol.27 (6), p.870-886

2021

Volltextzugriff (PDF)

Transcriptomic analysis of intestinal fibrosis‐associated gene expression in response to medical therapy in Crohn's disease

Inflammatory bowel diseases, 2008-09, Vol.14 (9), p.1197-1204

2008

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(116)
Tagungsberichte
(1)

Sprache

Englisch
(117)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(102)
Science & Technology
(102)
Gastroenterology & Hepatology
(101)
Humans
(78)
Female
(59)
Male
(57)
Adult
(54)
Middle Aged
(46)
Inflammatory Bowel Disease
(28)
Ulcerative Colitis
(28)
Crohn's Disease
(27)
Treatment Outcome
(24)
Colitis, Ulcerative - Drug Therapy
(21)
Crohn Disease - Drug Therapy
(21)
Young Adult
(20)
Retrospective Studies
(19)
Infliximab
(16)
Severity Of Illness Index
(16)
Gastrointestinal Agents - Therapeutic Use
(15)
Aged
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford journals
(117)
Journals@Ovid Complete
(116)
Oxford Journals 2020 Medicine
(115)
MEDLINE
(81)
Ingenta Connect
(71)
Elsevier ScienceDirect Journals Complete
(69)
Wiley Online Library All Journals
(43)
EZB Free E-Journals
(4)
Oxford Journals 2020 Humanities
(1)
IngentaConnect Journals
(1)
JSTOR
(1)
BMJ Journals
(1)
BMJ Journals Archiv - DFG Nationallizenzen
(1)

8 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates

Failure of MMP-9 Antagonists in IBD: Demonstrating the Importance of Molecular Biology and Well-Controlled Early Phase Studies

Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis

Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?

The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease

Efficacy of infliximab in refractory pouchitis and Crohn's disease‐related complications of the pouch: A Belgian case series

Long-term outcome after infliximab for refractory ulcerative colitis

Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases

ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD

Efficacy of JAK inhibitors in Ulcerative Colitis

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease

A Simplified Geboes Score for Ulcerative Colitis

Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease

Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD

Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window

Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis

Transcriptomic analysis of intestinal fibrosis‐associated gene expression in response to medical therapy in Crohn's disease

Aktive Filter

Suchergebnisse filtern